Mr. Richard Henriques joined Arbutus’s board of directors in December 2014. Mr. Henriques is currently a Senior Fellow at the University of Pennsylvania with a focus on impact investing. He formerly served as Chief Financial Officer for the Bill & Melinda Gates Foundation with responsibility for finance and accounting, financial planning and analysis, strategic planning, measurement and evaluation, program related investments and information technology. Mr. Henriques’ background includes more than 25 years working at Merck & Co., Inc. during which time, he served as Senior Vice President of Finance for Global Human Health, Vice President and Corporate Controller, and Principal Accounting Officer, among other financial management roles. Mr. Henriques currently serves as a board member for EMulate Therapeutics, a privately held Seattle based bio-electronics company and Cabaletta Bio, a Philadelphia based publicly listed biotechnology company focused on B cell-mediated autoimmune diseases. He is also a member of the board of directors for The Franklin Institute, The Heritage Conservancy in Buck’s County Pennsylvania and Episcopal Community Services (a Philadelphia based social services organization). He holds a B.A. in Oriental Studies from the University of Pennsylvania and an M.B.A. with a concentration in Finance from The Wharton School.